The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Kennedy said the picks will demand “definitive safety and efficacy data” for vaccine recommendations. His picks include at ...

The City of Thomasville is investigating a potential cybersecurity incident. City officials said the potential cybersecurity incident could involve its municipal systems.

With CDC upheaval, new limits on who can get some vaccines and an ongoing measles outbreak, parents like me face unfamiliar hurdles to protecting our kids.

North Carolina Republicans' effort to get rid of the state's concealed carry laws could run into some bipartisan opposition ...

No one warns you that stepping foot into a play centre during winter is like entering the Hunger Games… but with a lot more ...

Colorado Springs Mayor Yemi Mobolade is recovering from a bout with double pneumonia and a cleared blocked artery procedure ...

Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.

Approval of Enflonsia was based on data from the Phase IIb/III CLEVER trial, which showed a 60.5% reduction in medically ...

Vermont has the second lowest state fatality rate in the US (147.7 per 100K; Hawaii 113.3/100K). Mississippi (465.3/100K) and ...

The Food and Drug Administration (FDA) has approved Enflonsia ™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who ...